Triplet Therapy Slows Refractory Multiple Myeloma

WEDNESDAY, Nov. 18, 2020 -- A once-weekly regimen of selinexor, bortezomib, and dexamethasone slows the progression of relapsed or refractory multiple myeloma, according to a study published in the Nov. 14 issue of The Lancet. Sebastian Grosicki,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news